Continuation of Covered Calls Positions in Halozyme Therapeutics Inc.

Today the Covered Calls position in Halozyme Therapeutics Inc. (ticker HALO) was continued by selling four December 15th, 2023 $40.00 Calls at $1.72 per share.  After several recent weeks of decline, the stock price spiked higher today after its positive quarterly earnings report.  The transactions-to-date as well as potential return-on-investment results if assigned on the December 15th, 2023 options expiration date are detailed below.

Halozyme Therapeutics Inc. (HALO) -- Continuation of Covered Calls Position

The net debit buy/write limit order was executed as follows:

8/25/2023 Bought 400 shares of Halozyme Therapeutics stock @ $42.62 per share.  
8/25/2023 Sold 4 HALO September 15th, 2023 $40.00 Call options @ $3.36 per share.
Note: the Implied Volatility of the Calls was 38.8 when this position was established. 

9/15/2023 Continued this Halozyme Covered Calls position by selling 4 HALO October 20th, 2023 Call options at the $40.00 strike price for $2.00 per share.  The Halozyme share price was $40.22 when these Calls were sold and their Implied Volatility was 37.6.
10/20/2023 Four Calls expired out-of-the-money with the stock price below the $40.00 strike price, so 400 HALO shares remain in the Covered Calls Advisor Portfolio.

11/7/2023 Continued this Halozyme Covered Calls position by selling 4 HALO December 15th, 2023 Call options at the $40.00 strike price for $1.72 per share.  The Halozyme share price was $39.14 when these Calls were sold and their Implied Volatility was 41.0.

A possible overall performance result (including commissions) if this position is assigned on its 12/15/2023 options expiration date is follows:
Halozyme Covered Calls Net Investment: $15,706.68
= ($42.62 - $3.36) * 400 shares + $2.68 commission

Net Profit Components:
(a) Options Income: +$2,823.96
= ($3.36 + $2.00 + $1.72) * 400 shares - $8.04 commission
(b) Dividend Income: +$0.00
(c) Capital Appreciation (If Halozyme stock is above the $40.00 strike price on the December 15th expiration): -$1,048.00
= ($40.00 - $42.62) * 400 shares

Potential Total Net Profit (If assigned at expiration): +$1,775.96
= (+$2,823.96 options income + $0.00 dividend income - $1,048.00 capital appreciation)

Potential Absolute Return-on-Investment: +11.3%
= +$1,775.96/$15,706.68
Potential Equivalent Annualized-Return-on-Investment: +36.8%
= (+$1,775.96/$15,706.68) * (365/112 days)